# Core B - Molecular Pathology and Imaging Core (MPIC)

> **NIH NIH P01** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2021 · $323,219

## Abstract

PROJECT SUMMARY – CORE B 
The Molecular Pathology and Imaging Core (MPIC), Core B, is strategically designed to address the shared 
needs for tissue processing, histopathology, imaging, and expert analyses and is integral to all three projects of 
this P01. Established in 1995, the MPIC has been a critical part of this P01 since its inception in 2003 and has 
served as a model core facility for numerous other program projects and centers at the University of 
Pennsylvania and throughout the country. The overarching goal of the MPIC is to provide exceptional service 
and support to the esophageal cancer P01 investigators and their laboratories and is accomplished through 
two interrelated Specific Aims: (1) To provide essential, cost-effective, and high-quality services and support 
to the P01 investigators and their laboratories for the preparation, sectioning, staining, and interpretation of 
tissue sections, both animal and human, as well as cultured cells (interacting with CCiC), with particular 
expertise and focus on 3D organotypic/organoid cultures; and (2) To assist in planning and optimizing (a) in 
situ hybridization (ISH), immunohistochemistry (IHC), and immunofluorescence (IF) experiments, including for 
immuno-oncology, and (b) microscopy and image analyses for the P01 members and their laboratories and to 
provide training in these techniques, as well as perform these services as requested. The MPIC is led by an 
experienced Director (Dr. Jonathan Katz), Technical Director (Mr. Adam Bedenbaugh), and expert Consultant 
in esophageal and squamous cell pathology (mouse and human) (Dr. Andres Klein-Szanto). Integrating 
resources and services across all project sites, the MPIC is a unique entity at the University of Pennsylvania, 
the Medical University of South Carolina, the Dana Farber Cancer Institute and New York Institute with specific 
expertise in processing and analyses of all 3D organotypic cultures/organoid cultures and tissues (mouse, 
human) relevant to this P01. For P01 investigators and their laboratory personnel, the MPIC provides both 
essential, routine services and advanced technologies and approaches. The MPIC also fosters cost-effective 
approaches and promotes new and exciting directions for research. In addition, the MPIC offers special 
benefits to members of this P01 that are not available to other users, including esophageal cancer specific 
TMAs, significant subsidies for services, priority services, and access to Dr. Klein-Szanto, an expert clinical 
pathologist. Moreover, through consistent and validated approaches and standard protocols, the MPIC helps 
ensure rigor and reproducibility of experiments for P01 investigators and their laboratory members. Thus, the 
MPIC provides exceptional utility, quality, value, experience, service, and commitment to this P01's projects, 
cohesive coordination with other cores, and this P01 receives top priority.

## Key facts

- **NIH application ID:** 10214548
- **Project number:** 5P01CA098101-19
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** HANINA HIBSHOOSH
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $323,219
- **Award type:** 5
- **Project period:** 2003-08-15 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10214548

## Citation

> US National Institutes of Health, RePORTER application 10214548, Core B - Molecular Pathology and Imaging Core (MPIC) (5P01CA098101-19). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10214548. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*